No profile data available.
Novartis AG (NVS) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Basel, Switzerland, with about 75,267 full-time employees.
It reported revenue of $56.67 billion for fiscal year 2025, up 9.6% from fiscal year 2024, and net income of $13.98 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $14.95 billion, up 0.8% from a year before. United States was its largest region in fiscal year 2025, with 43% of revenue. Its market capitalization was $273.23 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
Novartis reported $56.67 billion in revenue for fiscal year 2025, up 9.6% from $51.72 billion in fiscal year 2024. In Q2 2026 revenue was $14.95 billion.
United States: 43% of revenue by region in fiscal year 2025, followed by Other (40%).
$273.23 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Johnson & Johnson (JNJ), AbbVie Inc. (ABBV), AstraZeneca PLC (AZN), Amgen Inc. (AMGN).